Medical Condition News RSS Feed - Medical Condition News

European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

The most representative snapshot of real world practice in cardiomyopathies in Europe has shown a higher than expected use of defibrillators and genetic testing. The baseline results of the ESC's EORP Cardiomyopathy Registry Pilot are presented for the first time today at ESC Congress 2015. [More]
Costs for spinal fusion vary substantially by region, shows new research

Costs for spinal fusion vary substantially by region, shows new research

Costs for spinal fusion vary substantially by region, with costs being lowest in the Midwest and highest in the Northeast, according to the new research by Dr. W. Ryan Spiker and colleagues of University of Utah, Salt Lake City. [More]
Report: 3 out of 4 U.S. adults have hearts older than their actual age

Report: 3 out of 4 U.S. adults have hearts older than their actual age

Your heart may be older than you are – and that's not good. According to a new CDC Vital Signs report, 3 out of 4 U.S. adults have a predicted heart age that is older than their actual age. This means they are at higher risk for heart attacks and stroke. [More]
Researchers explore how different facets of forgiveness affect feelings of depression in aging adults

Researchers explore how different facets of forgiveness affect feelings of depression in aging adults

Forgiveness is a complex process, one often fraught with difficulty and angst. Now, researchers in the University of Missouri College of Human Environmental Sciences studied how different facets of forgiveness affected aging adults' feelings of depression. [More]
Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers at the University of Maryland and the University of Virginia have performed the first focused ultrasound treatments in the United States for dyskinesia associated with Parkinson's disease. [More]
Finerenone drug improves albuminuria among patients with diabetes and kidney disease

Finerenone drug improves albuminuria among patients with diabetes and kidney disease

Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA. [More]
AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

Atrial fibrillation (AF) patients treated with rivaroxaban for stroke prevention have low rates of bleeding and stroke, reveals real-world data from the XANTUS study presented at ESC Congress today. [More]

Former all-American wrestler speaks about his personal battle with chronic muscle disease

In 2009, Mike Powell was where he'd always wanted to be. A former all-American wrestler himself, he'd returned to his Chicago-area high school to become the toughest wrestling coach around, inspiring young athletes with a brutal mix of love and punishing workouts. [More]
SKA2 gene may play a role in development of PTSD

SKA2 gene may play a role in development of PTSD

A gene linked in previous research, appears to predict more severe post-traumatic stress disorder (PTSD) symptoms as well as a thinner cortex in regions of the brain critical for regulating strong emotions and coping with stressful experiences. This study is believed to be the first to show that the spindle and kinetochore-associated complex subunit 2 (SKA2) gene may play a role in the development of PTSD. [More]
Familial hypercholesterolemia patients can benefit from alirocumab drug

Familial hypercholesterolemia patients can benefit from alirocumab drug

Alirocumab lowers cholesterol in patients with heterozygous familial hypercholesterolemia to levels unreachable with statins alone, according to results from four ODYSSEY trials presented at ESC Congress today. [More]
Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen today announced a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration accelerates Amgen's potential entry into Alzheimer's disease by teaming up with Novartis on a differentiated and genetically validated Alzheimer's disease program directed at genetically predisposed individuals at risk of developing Alzheimer's disease. [More]
ECHO Autism program to be expanded to additional 10 sites

ECHO Autism program to be expanded to additional 10 sites

Dr. Kristin Sohl, a pediatrician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, will expand the growing ECHO Autism program, which launched in March, to an additional 10 sites. [More]
Dementia brain imaging is helpful but not definitive, shows new research

Dementia brain imaging is helpful but not definitive, shows new research

MRI scans and other tools to detect and diagnose dementia are helpful but not definitive - according to new research from the University of East Anglia. [More]
AHA encourages parents to make healthy choices during Childhood Obesity Awareness Month

AHA encourages parents to make healthy choices during Childhood Obesity Awareness Month

The American Heart Association wants families to feel they can, and are fully equipped to, make healthy choices in the home and within their everyday activities - without throwing schedules completely off or leaving wallets empty. [More]
GSA, ASHG and Gruber Foundation announce recipients of 2016 Rosalind Franklin Young Investigator Award

GSA, ASHG and Gruber Foundation announce recipients of 2016 Rosalind Franklin Young Investigator Award

The Genetics Society of America (GSA), the American Society for Human Genetics (ASHG) and The Gruber Foundation are pleased to announce Maria Barna, PhD, of Stanford University; and Carolyn McBride, PhD, of Princeton University, as the 2016 recipients of the Rosalind Franklin Young Investigator Award. [More]
Diagnosing traumatic brain injury through a blood test: an interview with Dr Korley

Diagnosing traumatic brain injury through a blood test: an interview with Dr Korley

The severity of traumatic brain injury is currently crudely classified as mild, moderate or severe. However, often patients referred to as mild have debilitating symptoms that are not “mild”. Additionally, there are patients currently classified as moderate or severe who regain their pre-injury functional status whereas others don’t. [More]
Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCI

Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCI

Ticagrelor administered in the ambulance reduces ischaemic events 24 hours after primary percutaneous coronary intervention (PCI), according to findings from the ATLANTIC-H24 study presented for the first time today at ESC Congress. [More]
North Shore-LIJ researcher compares safety benefits two blood-thinning medications

North Shore-LIJ researcher compares safety benefits two blood-thinning medications

A large, ambitious contrast of blood-thinning medications used during cardiac stent placement suggests that a very expensive drug offers no clear safety benefits over a much more affordable option, according to a prominent North Shore-LIJ researcher and cardiologist. [More]
New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

New statistical model may help predict patients most likely to benefits from surgical treatment for mesothelioma

A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in the September 2015 issue of The Annals of Thoracic Surgery. [More]
Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

Finerenone effective in heart failure patients with diabetes and/or chronic kidney disease

In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP]. [More]
Advertisement
Advertisement